CG Oncology's successful IPO hints at a possible resurgence ...
CG Oncology's successful IPO hints at a possible resurgence of investor interest in biotech stocks, despite the sector's recent underperformance. This strong debut is viewed as a positive indicator for the sector's future.
Biotech's First IPO of 2024 Popped 96%. Good Times Could Be Ahead for the Stocks. -- Barrons.com
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment